StockMarketWire.com - Oddo today reaffirms its neutral investment rating on GlaxoSmithKline PLC [LON:GSK] and raised its price target to 1840p (from 1760p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk